- Retraction Note
- Open Access
Retraction Note: Down-regulation of miR-133a and miR-539 are associated with unfavorable prognosis in patients suffering from osteosarcoma
Cancer Cell International volume 16, Article number: 84 (2016)
- The original article was published in Cancer Cell International 2015 15:86
Retraction to: Cancer Cell Int (2015) 15:86 DOI 10.1186/s12935-015-0237-6
The Editors-in-Chief and Publisher have retracted this article  because the scientific integrity of the content cannot be guaranteed. An investigation by the Publisher found it to be one of a group of articles we have identified as showing evidence suggestive of attempts to subvert the peer review and publication system to inappropriately obtain or allocate authorship. This article showed evidence of plagiarism (most notably from the articles cited [2, 3]) and authorship manipulation.
Mirghasemi A, Taheriazam A, Karbasy SH, Torkaman A, Shakeri M, Yahaghi E, Mokarizadeh A. Down-regulation of miR-133a and miR-539 are associated with unfavorable prognosis in patients suffering from osteosarcoma. Cancer Cell Int. 2015;15:86. doi:10.1186/s12935-015-0237-6.
Ji F, Zhang H, Wang Y, Li M, Xu W, Kang Y, Wang Z, Wang Z, Cheng P, Tong D, Li C, Tang H. MicroRNA-133a, downregulated in osteosarcoma, suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1. Bone. 2013;56(1):220–6.
Bassampour SA, Abdi R, Bahador R, Shakeri M, Torkaman A, Yahaghi E, Taheriazam A. Downregulation of miR-133b/miR-503 acts as efficient prognostic and diagnostic factors in patients with osteosarcoma and these predictor biomarkers are correlated with overall survival. Tumor Biol. 2015. doi:10.1007/s13277-015-3918-9 (epub ahead of print).
The online version of the original article can be found under doi:10.1186/s12935-015-0237-6.
About this article
Cite this article
Mirghasemi, A., Taheriazam, A., Karbasy, S.H. et al. Retraction Note: Down-regulation of miR-133a and miR-539 are associated with unfavorable prognosis in patients suffering from osteosarcoma. Cancer Cell Int 16, 84 (2016). https://doi.org/10.1186/s12935-016-0359-5